Man Group PLC Summit Therapeutics Inc. Transaction History
Man Group PLC
- $49.7 Billion
- Q2 2025
A detailed history of Man Group PLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Man Group PLC holds 40,407 shares of SMMT stock, worth $763,288. This represents 0.0% of its overall portfolio holdings.
Number of Shares
40,407
Previous 19,005
112.61%
Holding current value
$763,288
Previous $366,000
134.7%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding SMMT
# of Institutions
267Shares Held
90.9MCall Options Held
4.71MPut Options Held
3.17M-
Baker Bros. Advisors LP New York, NY33.7MShares$637 Million7.27% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.67MShares$164 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$149 Million0.0% of portfolio
-
State Street Corp Boston, MA4.02MShares$75.9 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.91MShares$73.8 Million0.01% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.8B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...